San Francisco Bay Area biotech stories.
Wednesday, October 10, 2012
Longitude Capital closes $385M life sciences fund
Private equity firm Longitude Capital closed a fund that will invest in the life sciences after raising $385 million for it.
This fund, Longitude Venture Parnters II LP, will invest in drug development and medical technology. The firm had hoped to raise at least $325 million for it.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)